JPMorgan Chase & Co. Sees Unusually High Options Volume (NYSE:JPM)

Posted by Jeff Wilder on Jan 5th, 2026

JPMorgan Chase & Co. (NYSE:JPM) was the recipient of some unusual options trading on Monday. Stock traders purchased 264,572 call options on the stock. This represents an increase of approximately 305% compared to the typical daily volume of 65,350 call options.

Analysts Set New Price Targets

Several brokerages have recently commented on JPM. Weiss Ratings restated a “buy (b+)” rating on shares of JPMorgan Chase & Co. in a research note on Monday, December 22nd. Truist Financial raised their target price on JPMorgan Chase & Co. from $319.00 to $330.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Deutsche Bank Aktiengesellschaft upped their price objective on JPMorgan Chase & Co. from $300.00 to $320.00 and gave the company a “hold” rating in a research note on Tuesday, September 30th. Morgan Stanley set a $331.00 price target on shares of JPMorgan Chase & Co. in a research report on Tuesday, December 9th. Finally, Piper Sandler increased their price objective on JPMorgan Chase & Co. from $332.00 to $336.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Fifteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $332.00.

View Our Latest Stock Analysis on JPM

JPMorgan Chase & Co. Stock Up 2.9%

Shares of NYSE JPM traded up $9.29 during mid-day trading on Monday, hitting $334.77. 6,693,698 shares of the stock traded hands, compared to its average volume of 7,160,372. The company has a debt-to-equity ratio of 1.26, a quick ratio of 0.86 and a current ratio of 0.86. JPMorgan Chase & Co. has a 52 week low of $202.16 and a 52 week high of $337.25. The company has a market cap of $911.34 billion, a price-to-earnings ratio of 16.58, a PEG ratio of 1.60 and a beta of 1.07. The stock has a fifty day moving average price of $312.85 and a 200-day moving average price of $302.72.

JPMorgan Chase & Co. (NYSE:JPM – Get Free Report) last released its earnings results on Tuesday, October 14th. The financial services provider reported $5.07 EPS for the quarter, topping the consensus estimate of $4.83 by $0.24. The business had revenue of $47.12 billion for the quarter, compared to the consensus estimate of $44.42 billion. JPMorgan Chase & Co. had a return on equity of 17.18% and a net margin of 20.90%.The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the previous year, the company posted $4.37 earnings per share. Research analysts anticipate that JPMorgan Chase & Co. will post 18.1 EPS for the current year.

JPMorgan Chase & Co. Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Saturday, January 31st. Investors of record on Tuesday, January 6th will be paid a dividend of $1.50 per share. This represents a $6.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Tuesday, January 6th. JPMorgan Chase & Co.’s dividend payout ratio (DPR) is currently 29.72%.

Trending Headlines about JPMorgan Chase & Co.

Here are the key news stories impacting JPMorgan Chase & Co. this week:

Positive Sentiment: Wells Fargo raised its price target on JPM to $360 and kept an “overweight” rating — an analyst upgrade that supports further upside vs. the current share price and can attract momentum buyers. Wells Fargo raises PT on JPMorgan Chase to $360
Positive Sentiment: MarketWatch highlights JPMorgan joining the >$900B market-cap club and notes JPM is the cheapest stock in that elite group on valuation metrics — a relative-value narrative that can draw institutional flows into the shares. This is how JPMorgan Chase’s stock stands out in the elite $900 billion club
Positive Sentiment: CNBC reports JPMorgan launched “Special Advisory Services” to share parts of its proprietary capabilities with clients — a move that could deepen client relationships and create new fee revenue if adopted broadly. JPMorgan forms special advisory group to share some of bank’s ‘secret sauce’ with clients
Neutral Sentiment: J.P. Morgan’s high-profile Healthcare Conference is underway with many biotech presentations (e.g., Zealand Pharma), which boosts the firm’s franchise and deal pipeline visibility but has an indirect / longer-term impact on JPM’s results. Zealand Pharma to present at the J.P. Morgan Healthcare Conference
Neutral Sentiment: The New York Times piece on Jamie Dimon’s large 2025 compensation frames a broader story: deregulation and deal activity have helped bank profits, but high CEO pay can draw governance scrutiny. This is mostly a reputational/regulatory watch item rather than an immediate earnings swing. Dimon’s $770 Million Windfall Shows How Banking Is Great Again

Insider Buying and Selling

In related news, insider Robin Leopold sold 966 shares of the company’s stock in a transaction dated Friday, November 7th. The shares were sold at an average price of $311.92, for a total value of $301,314.72. Following the transaction, the insider owned 58,479 shares in the company, valued at approximately $18,240,769.68. This represents a 1.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.47% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On JPMorgan Chase & Co.

Institutional investors have recently modified their holdings of the stock. Harbor Asset Planning Inc. acquired a new position in JPMorgan Chase & Co. during the second quarter worth $26,000. Mountain Hill Investment Partners Corp. purchased a new stake in shares of JPMorgan Chase & Co. in the 3rd quarter valued at approximately $32,000. Family Legacy Financial Solutions LLC lifted its holdings in shares of JPMorgan Chase & Co. by 92.6% in the 3rd quarter. Family Legacy Financial Solutions LLC now owns 104 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 50 shares during the last quarter. Mizuho Securities Co. Ltd. boosted its position in shares of JPMorgan Chase & Co. by 450.0% during the 2nd quarter. Mizuho Securities Co. Ltd. now owns 110 shares of the financial services provider’s stock worth $32,000 after purchasing an additional 90 shares during the period. Finally, Turning Point Benefit Group Inc. purchased a new position in shares of JPMorgan Chase & Co. during the 3rd quarter worth approximately $35,000. Hedge funds and other institutional investors own 71.55% of the company’s stock.

About JPMorgan Chase & Co.

(Get Free Report)

JPMorgan Chase & Co (NYSE: JPM) is a diversified global financial services firm headquartered in New York City. The company provides a wide range of banking and financial products and services to consumers, small businesses, corporations, governments and institutional investors worldwide. Its operations span retail banking, commercial lending, investment banking, asset management, payments and card services, and treasury and securities services.

The firm’s principal business activities are organized across several core lines: Consumer & Community Banking, which offers deposit accounts, mortgages, auto loans, credit cards and branch and digital banking under the Chase brand; Corporate & Investment Banking, which provides capital markets, advisory, underwriting, trading and risk management services; Commercial Banking, delivering lending, treasury and capital solutions to middle-market and corporate clients; and Asset & Wealth Management, which offers investment management, private banking and retirement services to institutions and high-net-worth individuals.